Publication:
Confinement of Aβ1−40 Peptides in Liposome for Structural Characterization by Solid-State NMR

dc.contributor指導教授:陳振中
dc.contributor臺灣大學:化學研究所zh_TW
dc.contributor.authorYang, Chien-Ien
dc.creatorYang, Chien-Ien
dc.date2014
dc.date.accessioned2014-11-25T19:41:49Z
dc.date.accessioned2018-07-10T07:16:03Z
dc.date.available2014-11-25T19:41:49Z
dc.date.available2018-07-10T07:16:03Z
dc.date.issued2014
dc.description.abstractOne of the hallmarks of the Alzheimer’s disease (AD) is the amyloid plaques consisting of β-amyloid (Aβ) fibrils. Aβ oligomers have been considered as an important intermediate in the pathway of fibrillization, and are suggested to be the primary pathological species of AD. However, little is known about the molecular structure of Aβ oligomers because of their structural heterogeneity and transient nature. Therefore, we attempt to use liposomes to limit the fibrillization process by providing a confined space for Aβ1−40 in order to obtain stabilized oligomers, for which solid-state NMR technique can be utilized to identify the molecular structure. In this work, liposomes containing approximately 14% of Aβ1−40 monomers are synthesized with the reverse-phase evaporation method, which is more efficient than the thin-film liposome preparation method. However, instead of being confined by liposomes, the peptides form fibrils at a surprisingly low concentration of 3 μM. We propose that the liposomes may maintain a high local concentration of peptides, and may act as two-dimensional templates to accelerate the fibrillization of Aβ1−40. Solid-state NMR spectra reveal that the fibrils possess β-sheet secondary structure which is structurally different from oligomers prepared in buffer solution at 4 degrees Celsius. The chemical shift data of our fibril sample show significant difference from those reported for Tycko’s fibrils incubated in bulk solution. Additional experiments are required to confirm whether or not the structural distinction of our fibril sample is due to the modulation effect of liposomes.en
dc.description.tableofcontents謝誌……. i 中文摘要 iii Abstract… iv 縮寫表… v 第一章 緒論 1 1-1 類澱粉樣蛋白纖維 1 1-2 阿茲海默症以及Aβ胜肽所扮演的角色 5 1-3 不同形態的Aβ寡聚物 8 1-4 以固態核磁共振光譜探討Aβ聚合體之結構 10 1-5 Aβ寡聚物之穩定 14 1-6 微脂體及其製備方法之簡介 15 1-7 Aβ胜肽與脂質膜間的交互作用 18 1-8 研究動機 20 1-9 參考資料 20 第二章 合成與鑑定 29 2-1 材料與使用儀器 29 2-1-1 化學藥品 29 2-1-2 實驗儀器 31 2-2 胜肽製備 33 2-2-1 胜肽合成 33 2-2-2 胜肽純化 36 2-2-3 胜肽鑑定 37 2-3 Aβ1-40類澱粉樣纖維及寡聚物製備 39 2-4 包覆Aβ1-40單體之微脂體製備 40 2-4-1 LipoAβ製備—薄膜水合法 40 2-4-2 LipoAβ製備—逆相蒸發法 42 2-4-3 LipoAβ純化—凝膠管柱層析法 43 2-5 Aβ1-40類澱粉樣纖維、寡聚物及微脂體之鑑定 43 2-5-1 ThT螢光偵測 43 2-5-2 穿透式電子顯微鏡 45 2-5-3 動態光散射粒徑分佈儀 46 2-6 微脂體包覆率之檢測—斑點印迹法 48 2-7 Aβ1-40於微脂體內部之結構鑑定—固態核磁共振光譜 49 2-7-1 核磁共振基本原理 50 2-7-2 固態核磁共振技術 51 2-8 參考文獻 56 第三章 實驗結果與討論 59 3-1 胜肽的合成、純化與鑑定 59 3-2 Aβ1-40類澱粉樣纖維及寡聚物之鑑定 61 3-3 以微脂體包覆Aβ1-40單體 65 3-3-1 lipoAβ中Aβ1-40之含量 67 3-3-2 LipoAβ樣品中微脂體之鑑定 70 3-3-3 LipoAβ樣品中Aβ1−40之鑑定 73 3-4 Aβ1−40分子結構之鑑定−固態核磁共振光譜 76 3-5 結果討論 84 3-6 參考資料 86 第四章 結論及未來展望 89 4-1 論文總結 89 4-2 未來展望 89 4-3 參考資料 90 附錄……. 92 (一) 同位素標定之Aβ1−40鑑定 92 (二) 微脂體之Aβ1−40局部濃度計算 96zh_TW
dc.format.extent10655817 bytes
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://ntur.lib.ntu.edu.tw//handle/246246/261258
dc.identifier.uri.fulltexthttp://ntur.lib.ntu.edu.tw/bitstream/246246/261258/1/ntu-103-R01223110-1.pdf
dc.languagezh-TW
dc.rights論文公開時間:2015/08/11
dc.rights論文使用權限:同意有償授權(權利金給回饋學校)
dc.subject阿茲海默症zh_TW
dc.subject類澱粉樣蛋白zh_TW
dc.subject固態核磁共振zh_TW
dc.subject微脂體zh_TW
dc.titleConfinement of Aβ1−40 Peptides in Liposome for Structural Characterization by Solid-State NMRen
dc.typethesisen
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ntu-103-R01223110-1.pdf
Size:
23.32 KB
Format:
Adobe Portable Document Format